These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1471071)

  • 1. Interaction of heparin with myosin ATPase: possible involvement with the hemorrhagic activity and a correlation with antithrombin III high affinity-heparin molecules.
    Tersariol IL; Dietrich CP; Nader HB
    Thromb Res; 1992 Nov; 68(3):247-58. PubMed ID: 1471071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin.
    Dawes J
    Anal Biochem; 1988 Oct; 174(1):177-86. PubMed ID: 3218731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence of the C-6 sulfate of the glucosamine moiety and 1----4 glycosidic linkage of heparin disaccharides for production of hemorrhage: reversal of the antihemostatic activity of heparin and their fragments by adenosine triphosphate and myosin.
    Dietrich CP; Tersariol IL; Da Silva RG; Bianchini P; Nader HB
    Semin Thromb Hemost; 1991; 17 Suppl 1():65-73. PubMed ID: 1829853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P; Piepkorn M; Linker A
    Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional affinity resolution electrophoresis demonstrates that three distinct heparin populations interact with antithrombin III.
    Edens RE; Fromm JR; Fromm SJ; Linhardt RJ; Weiler JM
    Biochemistry; 1995 Feb; 34(8):2400-7. PubMed ID: 7873519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF; Ellis V; Shah N; Kakkar V
    Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of mammalian DNA topoisomerase I by heparin.
    Ishii K; Futaki S; Uchiyama H; Nagasawa K; Andoh T
    Biochem J; 1987 Jan; 241(1):111-9. PubMed ID: 3032152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant mechanisms of Orgaran (Org 10172) and its fraction with high affinity to antithrombin III (Org 10849).
    Ofosu FA
    Haemostasis; 1992; 22(2):66-72. PubMed ID: 1379966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effect of heparin and heparan sulphate on two abnormal antithrombin III type 3 variants.
    Fischer AM; Beguin S; Sternberg C; Dautzenberg MD
    Br J Haematol; 1987 Jun; 66(2):213-7. PubMed ID: 2955807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.
    Ofosu FA; Modi G; Cerskus AL; Hirsh J; Blajchman MA
    Thromb Res; 1982 Nov; 28(4):487-97. PubMed ID: 7164033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vivo hemorrhagic and antithrombotic effects of a low antithrombin-III affinity heparin fraction.
    Ockelford PA; Carter CJ; Cerskus A; Smith CA; Hirsh J
    Thromb Res; 1982 Sep; 27(6):679-90. PubMed ID: 7179209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human recombinant interleukin-1 beta- and tumor necrosis factor alpha-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells.
    Kobayashi M; Shimada K; Ozawa T
    J Cell Physiol; 1990 Sep; 144(3):383-90. PubMed ID: 2202741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
    Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
    Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexing of fibronectin glycosaminoglycans and collagen.
    Ruoslahti E; Engvall E
    Biochim Biophys Acta; 1980 Aug; 631(2):350-8. PubMed ID: 7407251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparan sulfate proteoglycan of endothelial cells: homocysteine suppresses anticoagulant active heparan sulfate in cultured endothelial cells].
    Nishinaga M; Shimada K
    Rinsho Byori; 1994 Apr; 42(4):340-5. PubMed ID: 8176841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence and circular dichroism studies during the interactions of sulfated polysaccharides with antithrombin III.
    Tanyi A; Benjamin V; Sadberry AJ; Doctor VM
    Thromb Res; 1995 Mar; 77(6):505-13. PubMed ID: 7542805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.